Merck: Access to Health

In collaboration with key stakeholders, we work to ensure our science advances health care, and our products are accessible and affordable to those in need.

Videos from this campaign

Content from this campaign

Sustainable Finance & Socially Responsible Investment

Advancing Health Equity Through Impact Investing
Despite incredible advances in science and medicine, significant gaps in access to quality health care still exist around the world. Impact investing is one way we are helping to bridge these gaps.

Health & Healthcare

Experts Discuss Importance of Cancer Screenings and Early Detection
In episode 5 of Teal Talks, Harris sits down with Dr. Laura Makaroff, SVP, prevention and early detection, American Cancer Society, and Merck’s Dr. Scot Ebbinghaus, and Steve Keefe, AVP, to discuss cancer prevention and advances in screening.

Health & Healthcare

Merck Joins Novartis-Led Collaboration To Increase Diversity in Clinical Trials
Through a new collaboration with Beacon of Hope, Merck will operate clinical trials through four Historically Black Medical School clinical trial Centers of Excellence.

Philanthropy & Cause Initiatives

35 Years: The Mectizan® Donation Program
In 1987, Merck committed to donate Mectizan – as much as needed, for as long as needed – with the goal to help eliminate river blindness.

Health & Healthcare

Taking Prostate Cancer Research Forward
Almost everyone knows somebody living with prostate cancer. But the people we know are not just a statistic or a number. They are our partners, parents, children, siblings and friends.

Health & Healthcare

Merck: The Vaccine Pioneers
The scientists who made giant strides in the fight against viral diseases included Jonas Salk and Albert Sabin. Dr. Maurice Hilleman, who led Merck’s Department of Virus and Cell Biology from 1957 to 1984, also belonged to that group of pioneers.

Health & Healthcare

Vaccines: Our History, Our Legacy
This was the desperate radio telegram in January 1925 from Dr. Curtis Welch in Nome, Alaska, to all the major Alaska towns, to territorial Governor Scott Bone in Juneau

Health & Healthcare

Merck and Ridgeback Announce Supply Agreement With UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the signing of a long-term supply agreement with the United Nations Children’s Fund (UNICEF) to facilitate broad global access for molnupiravir, an investigational

Philanthropy & Cause Initiatives

Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities
Merck, known as MSD outside the United States and Canada, announced an additional $150 million commitment through Merck for Mothers to further advance the initiative’s mission of helping create a world where no woman has to die giving life.

Responsible Business & Employee Engagement

Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort
Taking on COVID-19 isn’t just a team effort — it’s also a global one. Here at Merck, we’re grateful to all the people who have worked hard to keep us safe, along with everyone around the world helping to combat the pandemic.
Merck & Co., Inc. logo

More from Merck & Co., Inc.

  1. Merck: Employees
    We recognize that our ability to excel depends on the integrity, knowledge, imagination, skill, diversity and wellbeing of our employees.
  2. Merck: Access to Health
    In collaboration with key stakeholders, we work to ensure our science advances health care, and our products are accessible and affordable to those in...
  3. Merck: Ethics & Values
    Through our unwavering commitment to transparency, we earn the trust and confidence of our stakeholders.
  4. Merck: Environmental Sustainability
    We consider the impacts of our operations and strive to operate our business sustainably to support the health of our planet and its people.